About
FAQ
Partners
Press
Donate
Contact
Home
Meetings
Cognitive Science Society
Neuroethics
Beyond Belief
Stem Cell Meeting on the Mesa
Brains R Us: The Science of Educating
more »
Series
BRAIN Initiative
The Rightful Place
The Science Review
The Science Reader
The Science Studio
Et Cetera
Filmed Courses
12th EEGLAB Workshop
Raw Science
Home
»
Meetings
»
Industry/Academia Translational Oncology Symposium 2012
»
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies
Get the Flash Player
to see this player.
Loading the player ...
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies
Wendy Levin, Pfizer
Run Time:
16 minutes
Speakers:
Wendy Levin
Topics:
Cancer
DOWNLOAD Audio:
moorescancer-mar12-06-levin.mp3
Download
Report an issue with this video »
Industry/Academia Translational Oncology Symposium 2012
Moores Cancer Center
14 parts
March 22, 2012
Related Videos
Panel 1: Luke Lairson
George Martin
Panel 1: Ben Spike
Judith Campisi
Panel 1: Catriona Jamieson
Topics
Follow Us
Receive TSN updates on upcoming programs and announcements:
TSN Podcasts
Subscribe with iTunes
Or, copy and paste this URL into a podcasting tool: